BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21504204)

  • 1. Novel nitric oxide-releasing derivatives of farnesylthiosalicylic acid: synthesis and evaluation of antihepatocellular carcinoma activity.
    Ling Y; Ye X; Zhang Z; Zhang Y; Lai Y; Ji H; Peng S; Tian J
    J Med Chem; 2011 May; 54(9):3251-9. PubMed ID: 21504204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of nitric oxide-releasing derivatives of farnesylthiosalicylic acid as anti-tumor agents.
    Ling Y; Ye X; Ji H; Zhang Y; Lai Y; Peng S; Tian J
    Bioorg Med Chem; 2010 May; 18(10):3448-56. PubMed ID: 20435479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZL11n is a novel nitric oxide-releasing derivative of farnesylthiosalicylic acid that induces apoptosis in human hepatoma HepG2 cells via MAPK/mitochondrial pathways.
    Yang L; Ling Y; Zhang Z; Zhao Q; Tang J; Ji H; Zhang Y
    Biochem Biophys Res Commun; 2011 Jun; 409(4):752-7. PubMed ID: 21621522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New derivatives of farnesylthiosalicylic acid (salirasib) for cancer treatment: farnesylthiosalicylamide inhibits tumor growth in nude mice models.
    Goldberg L; Haklai R; Bauer V; Heiss A; Kloog Y
    J Med Chem; 2009 Jan; 52(1):197-205. PubMed ID: 19072665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of furoxan-based nitric oxide-releasing derivatives of glycyrrhetinic acid as anti-hepatocellular carcinoma agents.
    Lai Y; Shen L; Zhang Z; Liu W; Zhang Y; Ji H; Tian J
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6416-20. PubMed ID: 20932754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and anti-human hepatocellular carcinoma activity of new nitric oxide-releasing glycosyl derivatives of oleanolic acid.
    Huang Z; Zhang Y; Zhao L; Jing Y; Lai Y; Zhang L; Guo Q; Yuan S; Zhang J; Chen L; Peng S; Tian J
    Org Biomol Chem; 2010 Feb; 8(3):632-9. PubMed ID: 20090981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycosylated diazeniumdiolate-based oleanolic acid derivatives: synthesis, in vitro and in vivo biological evaluation as anti-human hepatocellular carcinoma agents.
    Huang Z; Fu J; Liu L; Sun Y; Lai Y; Ji H; Knaus EE; Tian J; Zhang Y
    Org Biomol Chem; 2012 May; 10(19):3882-91. PubMed ID: 22473516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
    Barkan B; Starinsky S; Friedman E; Stein R; Kloog Y
    Clin Cancer Res; 2006 Sep; 12(18):5533-42. PubMed ID: 17000690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.
    Liu L; Cao Y; Chen C; Zhang X; McNabola A; Wilkie D; Wilhelm S; Lynch M; Carter C
    Cancer Res; 2006 Dec; 66(24):11851-8. PubMed ID: 17178882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor platinum(II) complexes containing platinum-based moieties of present platinum drugs and furoxan groups as nitric oxide donors: synthesis, DNA interaction, and cytotoxicity.
    Zhao J; Gou S; Sun Y; Fang L; Wang Z
    Inorg Chem; 2012 Oct; 51(19):10317-24. PubMed ID: 22957695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
    Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H
    Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of novel farnesylthiosalicylic acid derivatives for cancer treatment.
    Ling Y; Wang X; Zhu H; Wang Z; Xu C; Wang X; Chen L; Zhang W
    Arch Pharm (Weinheim); 2014 May; 347(5):327-33. PubMed ID: 24435839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells.
    Chen KF; Yeh PY; Yeh KH; Lu YS; Huang SY; Cheng AL
    Cancer Res; 2008 Aug; 68(16):6698-707. PubMed ID: 18701494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the Ras oncoprotein reduces proliferation of hepatocytes in vitro and in vivo in rats.
    da Silva Morais A; Saliez A; Leclercq I; Horsmans Y; Stärkel P
    Clin Sci (Lond); 2008 Jan; 114(1):73-83. PubMed ID: 17678500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Farnesylthiosalicylic acid induces caspase activation and apoptosis in glioblastoma cells.
    Amos S; Redpath GT; Polar G; McPheson R; Schiff D; Hussaini IM
    Cell Death Differ; 2006 Apr; 13(4):642-51. PubMed ID: 16239932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel hybrids of (phenylsulfonyl)furoxan and anilinopyrimidine as potent and selective epidermal growth factor receptor inhibitors for intervention of non-small-cell lung cancer.
    Han C; Huang Z; Zheng C; Wan L; Zhang L; Peng S; Ding K; Ji H; Tian J; Zhang Y
    J Med Chem; 2013 Jun; 56(11):4738-48. PubMed ID: 23668441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined anti-tumor effects of IFN-α and sorafenib on hepatocellular carcinoma in vitro and in vivo.
    Wang L; Jia D; Duan F; Sun Z; Liu X; Zhou L; Sun L; Ren S; Ruan Y; Gu J
    Biochem Biophys Res Commun; 2012 Jun; 422(4):687-92. PubMed ID: 22634008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic antitumoral activity and induction of apoptosis by novel pan Bcl-2 proteins inhibitor apogossypolone with adriamycin in human hepatocellular carcinoma.
    Mi JX; Wang GF; Wang HB; Sun XQ; Ni XY; Zhang XW; Tang JM; Yang DJ
    Acta Pharmacol Sin; 2008 Dec; 29(12):1467-77. PubMed ID: 19026166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice.
    Zhang ZM; Yang XY; Deng SH; Xu W; Gao HQ
    Chin Med J (Engl); 2007 Aug; 120(15):1336-42. PubMed ID: 17711740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of 3'- and 5'-O-(3-benzenesulfonylfuroxan-4-yl)-2'-deoxyuridines: biological evaluation as hybrid nitric oxide donor-nucleoside anticancer agents.
    Moharram S; Zhou A; Wiebe LI; Knaus EE
    J Med Chem; 2004 Mar; 47(7):1840-6. PubMed ID: 15027876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.